Company · CIK 1696396
Stealth BioTherapeutics Corp
| CIK | 1696396 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | Cayman Islands |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-04-04 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-237542 | 2020-04-02 | 2022-11-17 | 10 | |
| 333-239356 | 2020-06-22 | 2022-11-17 | 3 | |
| 333-265423 | 2022-06-03 | 2022-11-17 | 3 | |
| 333-258533 | 2021-08-06 | 2022-06-03 | 2 | |
| 333-229097 | 2018-12-28 | 2019-02-15 | 7 |
Filings
28| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-11-17 | EFFECTDeclared effective | 333-265423 | 9999999995-22-003325 |
| 2022-11-17 | EFFECTDeclared effective | 333-239356 | 9999999995-22-003322 |
| 2022-11-17 | EFFECTDeclared effective | 333-237542 | 9999999995-22-003321 |
| 2022-06-15 | EFFECTDeclared effective | 333-265423 | 9999999995-22-001796 |
| 2022-06-03 | F-1Registration filed | 333-265423 | 0000950123-22-006796 |
| 2022-06-03 | RWWithdrawn | 333-258533 | 0000950123-22-006790 |
| 2022-04-11 | 424B5Shelf takedown | 333-237542 | 0000950170-22-005578 |
| 2022-04-07 | 424B5Shelf takedown | 333-237542 | 0000950123-22-003834 |
| 2022-03-18 | 424B5Shelf takedown | 333-237542 | 0001564590-22-011075 |
| 2021-08-06 | F-1Registration filed | 333-258533 | 0000950123-21-009739 |
| 2021-02-11 | 424B5Shelf takedown | 333-237542 | 0001193125-21-037392 |
| 2020-11-20 | 424B5Shelf takedown | 333-237542 | 0001193125-20-299465 |
| 2020-11-19 | 424B5Shelf takedown | 333-237542 | 0001193125-20-298271 |
| 2020-08-07 | 424B5Shelf takedown | 333-237542 | 0001193125-20-212240 |
| 2020-07-10 | EFFECTDeclared effective | 333-239356 | 9999999995-20-001763 |
| 2020-06-22 | F-1Registration filed | 333-239356 | 0001193125-20-175649 |
| 2020-04-10 | EFFECTDeclared effective | 333-237542 | 9999999995-20-000726 |
| 2020-04-02 | F-3Shelf registered | 333-237542 | 0001193125-20-094875 |
| 2020-02-20 | DRSDraft made public | 377-03060 | 0000950123-20-002646 |
| 2019-02-15 | 424B4Final prospectus | 333-229097 | 0001193125-19-042577 |
| 2019-02-14 | EFFECTDeclared effective | 333-229509 | 9999999995-19-000278 |
| 2019-02-14 | EFFECTDeclared effective | 333-229097 | 9999999995-19-000269 |
| 2019-02-14 | F-1/AAmendment | 333-229097 | 0001193125-19-039831 |
| 2019-02-08 | F-1/AAmendment | 333-229097 | 0001193125-19-032352 |
| 2019-02-06 | F-1/AAmendment | 333-229097 | 0001193125-19-029051 |
| 2019-01-30 | F-1/AAmendment | 333-229097 | 0001193125-19-021184 |
| 2018-12-28 | F-1Registration filed | 333-229097 | 0001193125-18-361101 |
| 2018-10-26 | DRSDraft made public | 377-02338 | 0000950123-18-010253 |